A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Enzalutamide
Related studies linked through entity extraction aliases.
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
- Status
- COMPLETED
- Phase
- N/A
A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
- Status
- RECRUITING
- Phase
- N/A
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
- Status
- COMPLETED
- Phase
- N/A
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Status
- RECRUITING
- Phase
- PHASE3
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Status
- RECRUITING
- Phase
- PHASE2
The COSMYC Trial (COmbined Suppression of MYC)
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer
- Status
- RECRUITING
- Phase
- N/A
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Status
- RECRUITING
- Phase
- PHASE2